Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002
Published online before print November 7, 2002, doi: 10.1161/01.RES.0000046018.23605.3E
A more recent version of this article appeared on December 13, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/12/1142    most recent
01.RES.0000046018.23605.3Ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Álvarez, A.
Right arrow Articles by Sanz, M.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Álvarez, A.
Right arrow Articles by Sanz, M.-J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
*LOSARTAN POTASSIUM
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors

Submitted on August 8, 2002
Revised on October 2, 2002
Accepted on October 29, 2002

Estrogens Inhibit Angiotensin II-Induced Leukocyte-Endothelial Cell Interactions In Vivo via Rapid Endothelial Nitric Oxide Synthase and Cyclooxygenase Activation

Ángeles Álvarez ; Carlos Hermenegildo ; Andrew C. Issekutz ; Juan V. Esplugues ; and Maria-Jesus Sanz *

From the Department of Pharmacology (A.A., J.V.E., M.-J.S.), Faculty of Medicine, and Research Unit (C.H.), Clinic Hospital, University of Valencia, Spain, and Departments of Pediatrics, Pathology, Microbiology, and Immunology (A.C.I.), Dalhousie University, Halifax, Nova Scotia, Canada.

* To whom correspondence should be addressed. E-mail: maria.j.sanz{at}uv.es.

Angiotensin II (Ang II) may be a key molecule in the development of atherosclerosis. Because the incidence of coronary atherosclerosis in premenopausal women is lower than that observed in men or postmenopausal women, we have investigated the effect of estrogens on Ang II-induced leukocyte recruitment in vivo using intravital microscopy in the rat mesenteric microcirculation. Superfusion for 60 minutes with Ang II induced a significant increase in leukocyte rolling flux, adhesion, and emigration. Administration of 17-{beta}-estradiol (17-{beta}-E) after 30 minutes of Ang II superfusion produced a reduction of these leukocyte responses by 55.1%, 72.7%, and 70.9%, respectively, an additional 30 minutes later. The effect observed with 17-{beta}-E was receptor-mediated and specific. 17-{beta}-E superfusion did not modify either L-NAME or indomethacin-induced leukocyte responses. Inhibitory responses caused by 17-{beta}-E were not altered by either 7-nitroindazole or actinomycin D cosuperfusion. Stimulation of endothelial cells with 17-{beta}-E caused a rapid and dose-dependent release of prostacyclin. Finally, tamoxifen or ICI 182,780 administration provoked a significant increase in leukocyte-endothelial cell interactions 90 minutes later, which were significantly attenuated by systemic preadministration with an Ang II AT1 receptor antagonist. Tamoxifen-induced leukocyte responses were also reduced by systemic pretreatment with an anti-P-selectin mAb and an anti-CD18 mAb. Hence, the antiatherogenic effects of estrogens may be mediated by inhibition of Ang II-induced leukocyte recruitment through endothelial NO and prostacyclin release. Furthermore, scarcity of estrogens resulted in decreased levels of vasodilators and the exposure of the endothelium to the deleterious action of Ang II, which may explain the higher incidence of coronary atherosclerosis in men and postmenopausal women.


Key words: leukocytes • endothelium • cell adhesion molecules • intravital microscopy • prostacyclin




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Abu-Taha, C. Rius, C. Hermenegildo, I. Noguera, J.-M. Cerda-Nicolas, A. C. Issekutz, P. J. Jose, J. Cortijo, E. J. Morcillo, and M.-J. Sanz
Menopause and Ovariectomy Cause a Low Grade of Systemic Inflammation that May Be Prevented by Chronic Treatment with Low Doses of Estrogen or Losartan
J. Immunol., July 15, 2009; 183(2): 1393 - 1402.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. L. Yanes, J. C. Sartori-Valinotti, and J. F. Reckelhoff
Sex Steroids and Renal Disease: Lessons From Animal Studies
Hypertension, April 1, 2008; 51(4): 976 - 981.
[Full Text] [PDF]


Home page
HypertensionHome page
S. Hagita, M. Osaka, K. Shimokado, and M. Yoshida
Oxidative Stress in Mononuclear Cells Plays a Dominant Role in Their Adhesion to Mouse Femoral Artery After Injury
Hypertension, March 1, 2008; 51(3): 797 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Alvarez, M. S. Ibiza, M. M. Andrade, A. Blas-Garcia, and S. Calatayud
Gastric Antisecretory Drugs Induce Leukocyte-Endothelial Cell Interactions through Gastrin Release and Activation of CCK-2 Receptors
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 406 - 413.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Alvarez, S. Ibiza, C. Hernandez, A. Alvarez-Barrientos, J. V. Esplugues, and S. Calatayud
Gastrin induces leukocyte-endothelial cell interactions in vivo and contributes to the inflammation caused by Helicobacter pylori
FASEB J, November 1, 2006; 20(13): 2396 - 2398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Park, J. I. Kim, Y. Ahn, A. J. Bonventre, and J. V. Bonventre
Testosterone Is Responsible for Enhanced Susceptibility of Males to Ischemic Renal Injury
J. Biol. Chem., December 10, 2004; 279(50): 52282 - 52292.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Xing, A. Miller, L. Novak, R. Rocha, Y.-F. Chen, and S. Oparil
Estradiol and Progestins Differentially Modulate Leukocyte Infiltration After Vascular Injury
Circulation, January 20, 2004; 109(2): 234 - 241.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Garbe and S. Suissa
Issues to debate on the Women's Health Initiative (WHI) study: Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies
Hum. Reprod., January 1, 2004; 19(1): 8 - 13.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Martin-McNulty, D. M. Tham, V. da Cunha, J. J. Ho, D. W. Wilson, J. C. Rutledge, G. G. Deng, R. Vergona, M. E. Sullivan, and Y.-X. Wang
17{beta}-Estradiol Attenuates Development of Angiotensin II-Induced Aortic Abdominal Aneurysm in Apolipoprotein E-Deficient Mice
Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1627 - 1632.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Bregonzio, I. Armando, H. Ando, M. Jezova, G. Baiardi, and J. M. Saavedra
Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury
Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G414 - G423.
[Abstract] [Full Text] [PDF]